Ident. | Authors (with country if any) | Title |
---|
000056 (2014) |
J. J. Brugts [Pays-Bas] ; Hisatomi Arima [Australie] ; W. Remme [Pays-Bas] ; M. Bertrand [France] ; R. Ferrari [Italie] ; K. Fox [Royaume-Uni] ; J. Dinicolantonio [États-Unis] ; S. Macmahon [Australie] ; J. Chalmers [Australie] ; F. Zijlstra [Pays-Bas] ; K. Caliskan [Pays-Bas] ; M. L. Simoons [Pays-Bas] ; J. J. Mourad [France] ; E. Boersma [Pays-Bas] ; K. M. Akkerhuis [Pays-Bas] | The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease |
001B55 (2011) |
Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Christian Funck-Brentano [France] ; Emilio Vanoli [Italie] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Piotr Ponikowski [Pologne] ; Michael Goulder [Royaume-Uni] ; Wilfried Meyer [Allemagne] ; Philippe Lechat [France] ; Ronnie Willenheimer [Suède] | Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial |
001E05 (2011) |
Jasper J. Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; K. Martijn Akkerhuis [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Jacqueline C. M. Witteman [Pays-Bas] ; Francois Cambien [France] ; Claudio Ceconi [Italie] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Stephen Harrap [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Maarten L. Simoons [Pays-Bas] ; A. H. Jan Danser [Pays-Bas] | A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals |
002389 (2010) |
Jasper Jan Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Claudio Ceconi [Italie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Jacqueline C. M. Witteman [Pays-Bas] ; A. H. Jan Danser [Pays-Bas] ; Maarten L. Simoons [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] | Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease |
002768 (2009) |
Jasper J. Brugts [Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Eric Boersma [Pays-Bas] ; Willem J. Remme [Pays-Bas] ; Michel Bertrand [France] ; Roberto Ferrari [Italie] ; Kim Fox [Royaume-Uni] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] ; Maarten L. Simoons [Pays-Bas] | The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials |
004414 (2005) |
Michael F. O'Rourke [Australie] ; Michel E. Safar [France] | Relationship between aortic stiffening and microvascular disease in brain and kidney : Cause and logic of therapy |
004431 (2005) |
Henry Krum [Australie] ; Steven Joseph Haas [Australie] ; Eric Eichhorn [États-Unis] ; Jalal Ghali [États-Unis] ; Edward Gilbert [États-Unis] ; Philippe Lechat [France] ; Milton Packer [États-Unis] ; Ellen Roecker [États-Unis] ; Patricia Verkenne [Allemagne] ; Hans Wedel [Suède] ; John Wikstrand [Suède] | Prognostic benefit of beta-blockers in patients not receiving ACE-inhibitors |
004642 (2005) |
Ronnie Willenheimer [Suède] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Allan Skene [Royaume-Uni] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France] | Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence : Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III |
004867 (2004) |
Jean-Michel Mallion [France] ; Bernard Chamontin [France] ; Roland Asmar [France] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Eoin O'Brien [Irlande (pays)] ; Daniel Duprez [Belgique, États-Unis] ; Michael F. O'Rourke [Australie] ; Karl-Heinz Rahn [Allemagne] ; Ramon Romero [Espagne] ; Edouard Battegay [Suisse] ; Gerhart Hitzenberger [Autriche] ; Michel E. Safar [France] | Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: The REASON study |
004A11 (2004) |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
004B73 (2004) |
N. Chapman [Royaume-Uni] ; R. Huxley [Australie] ; C. Anderson [Nouvelle-Zélande] ; M. G. Bousser [France] ; J. Chalmers [Australie] ; S. Colman [Australie] ; S. Davis [Australie] ; G. Donnan [Australie] ; S. Macmahon [Australie] ; B. Neal [Australie] ; C. Warlow [Royaume-Uni] ; M. Woodward [Australie] | Effects of a perindopril-based blood pressure-lowering regimen on the risk of Recurrent Stroke according to Stroke subtype and medical history: The PROGRESS trial |
004B74 (2004) |
Duncan J. Campbell [Australie] ; Theodora Alexiou [Australie] ; Hong D. Xiao [Australie] ; Sebastien Fuchs [Australie] ; Michael J. Mckinley [Australie] ; Pierre Corvol [France] ; Kenneth E. Bernstein [Australie] | Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice |
004D28 (2003) |
John Chalmers [Australie] | Etude ADVANCE: objectifs, protocole et état actuel |
005300 (2002) |
Victor J. Dzau [États-Unis] ; Kenneth Bernstein [États-Unis] ; David Celermajer [Australie] ; Jerome Cohen [États-Unis] ; Björn Dahlöf [Suède] ; John Deanfield [Royaume-Uni] ; Javier Diez [Espagne] ; Helmut Drexler [Allemagne] ; Roberto Ferrari [Italie] ; Wiek Van Gilst [Pays-Bas] ; Lennart Hansson [Suède] ; Burkhard Hornig [Allemagne] ; Ahsan Husain [Australie] ; Colin Johnston [Australie] ; Harold Lazar [États-Unis] ; Eva Lonn [Canada] ; Thomas Lüscher [Suisse] ; John Mancini [Canada] ; Albert Mimran [France] ; Carl Pepine ; Ton Rabelink ; Willem Remme ; Luis Ruilope ; Marcel Ruzicka ; Heribert Schunkert ; Karl Swedber ; Thomas Unger ; Douglas Vaughan ; Michael Weber | Pathophysiologic and therapeutic importance of tissue ACE: A consensus report |
005833 (2001) |
Roland G. Asmar [France] ; Gérard M. London [France] ; Michael E. O'Rourke [Australie] ; Michel E. Safar [France] | Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol |
005952 (2001) |
Tazeen H. Jafar [États-Unis, Italie, Danemark, Australie, Suède, France, Pays-Bas] ; Christopher H. Schmid ; Marcia Landa ; Loannis Giatras ; Robert Toto ; Giuseppe Remuzzi ; Giuseppe Maschio ; Barry M. Brenner ; Annelise Kamper ; Pietro Zucchelli ; Gavin Becker ; Andres Himmelmann ; Kym Bannister ; Paul Landais ; Shahnaz Shahinfar ; Paul E. De Jong ; Dick De Zeeuw ; Joseph Lau ; Andrew S. Levey | Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A Meta-Analysis of Patient-Level Data |
006016 (1999) |
JIN BO SU [France] ; F. Barbe [France] ; B. Crozatier [France] ; D. J. Campbell [Australie] ; L. Hittinger [France] | Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure |
006065 (1999) |
A. Castaigne [France] ; J. Chalmers [Australie] ; T. Morgan [Australie] ; C. Chastang [France] ; L. Feldmann [France] ; D. Guez [France] | Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination : A randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension |